Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc J Claeys

Showing results (1-10 of 120) with videos related to

Pageof 12
Sort By:
JAMA Internal Medicine|December 9, 2014
Is primary percutaneous coronary intervention still the superior reperfusion strategy?Marc J Claeys
Acta Cardiologica|January 19, 2022
Reperfusion injury in STEMI patients: another piece of the puzzleMarc J Claeys
Seminars in Vascular Medicine|June 17, 2004
Antiplatelet therapy for elective coronary stenting: a moving targetMarc J Claeys
European Heart Journal|May 21, 2014
High-sensitivity troponin: does it predict the shape of the iceberg underneath the surface?Marc J Claeys
JACC. Cardiovascular Imaging|August 22, 2021
Annular Dynamics in Patients With Atrial Fibrillation and AFMR: The Next Piece of the PuzzleCaroline M Van De Heyning, Marc J Claeys
Acta Cardiologica|November 12, 2017
Quality assessment in percutaneous coronary interventions: the QERMID Belgian PCI registryClaude Hanet, Marc J Claeys, Marc Carlier, et al.
Acta Cardiologica|November 25, 2021
Summary of 2020 ESC guidelines on non-STE ACS, adult congenital heart disease, sports cardiology and atrial fibrillationMarc J Claeys, Antoine Bondue, Patrizio Lancellotti, et al.
Acta Cardiologica|February 11, 2022
Review article: the best of 2019Marc J Claeys, Michel De Pauw, Patrizio Lancellotti, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 17, 2023
In-hospital initiation of PCSK9 inhibitors in ACS: pros and consKonstantin A Krychtiuk, Marc J Claeys, Baris Gencer, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 27, 2017
Real world insights on the initiation and treatment duration of oral antiplatelets in acute coronary syndromes: a retrospective cohort studyMarc J Claeys, Christophe Beauloye, Suzanne Pourbaix, et al.
Pageof 12

Showing results (1-10 of 120) with videos related to

Sort By:
Pageof 12
JAMA Internal Medicine|December 9, 2014
Is primary percutaneous coronary intervention still the superior reperfusion strategy?Marc J Claeys
Acta Cardiologica|January 19, 2022
Reperfusion injury in STEMI patients: another piece of the puzzleMarc J Claeys
Seminars in Vascular Medicine|June 17, 2004
Antiplatelet therapy for elective coronary stenting: a moving targetMarc J Claeys
European Heart Journal|May 21, 2014
High-sensitivity troponin: does it predict the shape of the iceberg underneath the surface?Marc J Claeys
JACC. Cardiovascular Imaging|August 22, 2021
Annular Dynamics in Patients With Atrial Fibrillation and AFMR: The Next Piece of the PuzzleCaroline M Van De Heyning, Marc J Claeys
Acta Cardiologica|November 12, 2017
Quality assessment in percutaneous coronary interventions: the QERMID Belgian PCI registryClaude Hanet, Marc J Claeys, Marc Carlier, et al.
Acta Cardiologica|November 25, 2021
Summary of 2020 ESC guidelines on non-STE ACS, adult congenital heart disease, sports cardiology and atrial fibrillationMarc J Claeys, Antoine Bondue, Patrizio Lancellotti, et al.
Acta Cardiologica|February 11, 2022
Review article: the best of 2019Marc J Claeys, Michel De Pauw, Patrizio Lancellotti, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 17, 2023
In-hospital initiation of PCSK9 inhibitors in ACS: pros and consKonstantin A Krychtiuk, Marc J Claeys, Baris Gencer, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 27, 2017
Real world insights on the initiation and treatment duration of oral antiplatelets in acute coronary syndromes: a retrospective cohort studyMarc J Claeys, Christophe Beauloye, Suzanne Pourbaix, et al.
Pageof 12